参考文献/References:
[1] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J].中国循环杂志,2021,36(6):521-545.
[2] Li Y,Liu H,Peng W,et al.Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI:A systematic review and meta-analysis of 14 randomized trials[J].Expert Rev Clin Pharmacol,2018,11(9):855-865.
[3] 王 显.经皮冠状动脉介入治疗术后胸痛中医诊疗专家共识[J].中医杂志,2014,55(13):1167-1170.
[4] Neumann FJ,Sousa UM,Ahlsson A,et al.2018 ESC/EACTS guidelines on myocardial revascularization[J].Eur Heart Journal,2019,40(2):87-165.
[5] Tobaru T.Importance of guideline adherence for unstable angina pectoris and prevention of serious cardiovascular events by conforming to guidelines[J].Journal Cardiol,2015,66(2):99-100.
[6] 王凤琴,陈 岑,夏之宁,等.血小板在活血化瘀中药研究中的应用[J].中国中药杂志,2014,39(16):2993-3003.
[7] 付占宇,李相中.益气通脉汤对冠心病心绞痛患者心功能及血液流变学的影响[J].临床医学,2020,40(8):113-115.
[8] 中华医学会心血管病分会,中华心血管病编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2019,47(10):766-783.
[9] Hani J.2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction[J].Journal of the American College of Cardiology,2012,60(7):645-681.
[10] 李承辉.血府逐瘀汤对冠心病行介入治疗术后患者心绞痛的影响[J].世界最新医学信息文摘,2015,15(3):199,204.
[11] 王 娟.血府逐瘀汤对冠心病行介入治疗术后患者心绞痛的影响[J].中西医结合心血管病电子杂志,2014,2(16):91-92.
[12] 康峰光,钟玉娟.血府逐瘀汤对冠心病支架术后心绞痛患者血清IL-33/sST2表达的影响[J].黑龙江中医药,2021,50(1):96-97.
[13] 徐迦勒,姜钧文.血府逐瘀汤加减治疗PCI术后稳定型心绞痛气滞血瘀型临床观察[J].云南中医中药杂志,2022,43(2):29-32.
[14] 张 进.血府逐瘀汤治疗冠心病支架术后心绞痛的疗效观察[J].医学信息,2015,28(41):32.
[15] 姜志坤.血府逐瘀汤加减治疗冠心病介入术后心绞痛临床研究[J].健康必读,2021,28(14):31.
[16] 崔长锋.血府逐瘀汤加味辅助治疗冠状动脉支架植入术后心绞痛效果分析[J].疾病监测与控制,2017,11(7):581-582.
[17] 陈 滨.血府逐瘀汤加味治疗冠状动脉支架植入术后心绞痛的临床效果探究[J].当代医学,2016,22(12):154-155.
[18] 朱 巧,刘春娜,于维娜.血府逐瘀汤加味治疗冠状动脉支架植入术后心绞痛的临床观察[J].中国中西医结合急救杂志,2010,17(5):298-301.
[19] 吴继雷,王凤荣.血府逐瘀汤治疗冠脉血运重建后胸痛(心绞痛)心血瘀阻证临床观察[J].中国中医药现代远程教育,2020,18(10):74-76.
[20] 陈 瑶.血府逐瘀汤治疗冠心病介入术后心绞痛的临床研究[J].黑龙江科学,2019,10(22):58-59.
[21] 刘 红,张玲燕,杨 玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,40(5):594-596.
[22] 符惠娟.血府逐瘀汤治疗急性心肌梗死经皮冠状动脉穿刺术后心绞痛临床评价[J].中国药业,2019,28(s1):33-34.
[23] 郭殿选,刘 涛,潘长江,等.炎症反应和氧化应激对老年人经皮冠状动脉介入治疗术后再发心绞痛的影响[J].中华老年医学杂志,2020,39(10):1205-1207.
[24] 唐荣欣,刘新灿,刘明扬,等.远程缺血预适应联合体外反搏在PCI术后心绞痛病人中的应用[J].护理研究,2020,34(22):4082-4084.
[25] Wang R,Lu J,Yin J,et al.A Tempol and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation[J].Bioact Mater,2022,11(5):666-677.
[26] Bajraktari G,Bytyci I,Bajraktari A,et al.Non-inferiority of one month versus longer dual antiplatelet therapy in patients undergoing PCI with drug-eluting stents:A systematic review and meta-analysis of randomized clinical trials[J].Ther Adv Chronic Dis,2022,17(5):3749-3758.
[27] 冯 君,刘建和,冉俊宁,等.从痰、瘀、虚探讨动脉粥样硬化的中西医病机[J].陕西中医,2020,41(2):217-219.
[28] 冯 娟,闫奎坡,朱明军,等.瓜蒌薤白半夏汤联合血府逐瘀汤从痰瘀论治冠心病心绞痛疗效Meta分析[J].陕西中医,2021,42(3):393-397.
[29] 李伟霞,泥文娟,王晓艳,等.当归化学成分、药理作用及其质量标志物(Q-marker)的预测分析[J].中华中医药学刊,2022,40(6):40-47,274.
[30] 吴玲芳,王子墨,赫柯芊,等.赤芍的化学成分和药理作用研究概况[J].中国实验方剂学杂志,2021,27(18):198-206.
[31] Meng Q,Liu H,Wu H,et al.A Network pharmacology study to explore the underlying mechanism of safflower in the treatment of coronary heart disease[J].Evid Based Complement Alternat Med,2022,14(5):324-335.
[32] 陈金鹏,张克霞,刘 毅,等.地黄化学成分和药理作用的研究进展[J].中草药,2021,52(6):1772-1784.
[33] 张妍妍,韦建华,卢澄生,等.桃仁化学成分、药理作用及质量标志物的预测分析[J].中华中医药学刊,2022,40(1):234-241.
[34] Shi J,Li R,Yang S,et al.The protective effects and potential mechanisms of ligusticum chuanxiong:Focus on anti-inflammatory antioxidant and antiapoptotic activities[J].Evid Based Complement Alternat Med,2020,19(10):8205-8209.
[35] 杨 斌,芮轶群,王 欢,等.血府逐瘀汤治疗心绞痛的分子机制预测[J].中医药临床杂志,2022,34(1):88-95.
[36] 王 晶,刘易婷,刘 哲.替米沙坦联合瑞舒伐他汀治疗糖尿病合并冠心病对患者外周胰岛素抵抗、糖化血红蛋白、脂蛋白和心肌缺血的影响[J].陕西医学杂志,2022,51(5):595-598.
相似文献/References:
[1]郭辉.温阳通脉方联合氯吡格雷治疗不稳定型心绞痛临床观察[J].陕西中医,2017,(06):692.
[2]李娜,陈雪斌,王利民,等.活血通络方对冠心病心绞痛患者血液流变学和心电图心率变异性的影响[J].陕西中医,2018,(11):1551.
[3]朱 薇.通脉调脂方治疗冠心病稳定性心绞痛疗效及对患者血流变、VCAM1〖JZ〗及ICAM1影响的研究*[J].陕西中医,2019,(3):290.
ZHU Wei..Effect of Tongmai Tiaozhi recipe on the efficacy, Hemorheology, VCAM1 and ICAM1 〖JZ〗in patients with stable angina pectoris of coronary heart disease[J].,2019,(3):290.
[4]刘 红,张玲燕,杨 玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,(5):594.
LIU Hong,ZHANG Lingyan,YANG Ling..Clinical observation of Xuefu Zhuyu decoction in the treatment of angina pectoris after PCI for coronary heart disease[J].,2019,(3):594.
[5]贺建涛,胡宇才,刘 磊.活血通络散治疗冠心病PCI术后心绞痛疗效研究*[J].陕西中医,2019,(7):854.
HE Jiantao,HU Yucai,LIU Lei..Efficacy observation of Huoxue Tongluo powder in the treatment of angina pectoris after coronary heart disease PCI[J].,2019,(3):854.
[6]时文才,聂晨旭,胡晓龙,等.黄芪桂枝五物汤合血府逐瘀汤联合针灸治疗早期强直性脊柱炎临床研究*[J].陕西中医,2020,(3):315.
[7]蔡宝石,李 玲,李 梅,等.血府逐瘀汤联合双胍类降糖药治疗糖尿病疗效研究[J].陕西中医,2020,(6):774.[doi:DOI:10.3969/j.issn.10007369.2020.06.020]
CAI Baoshi,LI Ling,LI Mei,et al.Analysis of the clinical effect of Xuefu Zhuyu decoction combined with biguanide hypoglycemic drugs in the treatment of diabetes mellitus[J].,2020,(3):774.[doi:DOI:10.3969/j.issn.10007369.2020.06.020]
[8]钱 伟,白 桦,郝志晔△.养心通脉汤治疗心绞痛疗效及对患者炎性反应指标和血管内皮功能的影响*[J].陕西中医,2020,(11):1591.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.020]
QIAN Wei,BAI Hua,HAO Zhiye..Effect of Yangxin Tongmai decoction on the inflammatory response and thromboxane of patients with angina pectoris[J].,2020,(3):1591.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.020]
[9]冯 娟,闫奎坡,朱明军,等.瓜蒌薤白半夏汤联合血府逐瘀汤从痰瘀论治冠心病心绞痛疗效Meta分析[J].陕西中医,2021,(3):393.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.033]
[10]魏明娜,朱建贵.血府逐瘀汤联合劳拉西泮治疗老年2型心肾综合征稳定期伴有睡眠障碍临床研究[J].陕西中医,2021,(4):438.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.008]